UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028096
Receipt number R000032113
Scientific Title The Association with Geriatric Nutritional Risk Index, ADL, and Clinical Outcomes in Patients on Chronic Hemodialysis.
Date of disclosure of the study information 2017/07/24
Last modified on 2023/07/11 14:13:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Association with Geriatric Nutritional
Risk Index, ADL, and Clinical Outcomes in Patients on Chronic Hemodialysis.

Acronym

The Association with Geriatric Nutritional
Risk Index, ADL, and Clinical Outcomes in Patients on Chronic Hemodialysis.

Scientific Title

The Association with Geriatric Nutritional
Risk Index, ADL, and Clinical Outcomes in Patients on Chronic Hemodialysis.

Scientific Title:Acronym

The Association with Geriatric Nutritional
Risk Index, ADL, and Clinical Outcomes in Patients on Chronic Hemodialysis.

Region

Japan


Condition

Condition

End-stage renal disease, Sarcopenia, Hypertension, Dyslipidemia, Diabetes mellitus

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism
Nephrology Geriatrics Orthopedics
Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We investigated the association with GNRI(Geriatric Nutritional Risk Index) and the ability of walking, which patient can walk by oneself or not, and mortality from all causes in HD patients.

Basic objectives2

Others

Basic objectives -Others

Association with GNRI and the ability of walking

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Can walk by oneself or not.

Key secondary outcomes

Mortality from all causes, Incidence of bone fracture and hospitalization, Change of BBS(Berg Balance Scale), TUG(Timed Up to Go), 10 meter Walking Test, and FIM(Function Independence Measure).


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients who underwent HD in Sugitagenpakukinen Kouritu Obama Hospital between April 1st 2011 and March 31st 2016.
2.Patients who underwent whole bone densitometry.
3.Age : Not applicable
4.Gender : Not applicable
5.Duration of HD/Primary disease of HD : Not applicable

Key exclusion criteria

1.Patients who, started HD during this observation period, died of senility within 3 months after the HD started.
2.Patients who, started HD before this observation period, died of senility within May 30th 2011.
3.Patients who were read to be ineligible by principal investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tokuharu Tanaka

Organization

Sugitagenpakukinen Kouritu Obama Hospital

Division name

Department of Internal Medicine

Zip code


Address

2-2 Oote-cho, Obama-shi, Fukui, Japan

TEL

0770-52-0990

Email

tnktya@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Tokuharu Tanaka

Organization

Sugitagenpakukinen Kouritu Obama Hospital

Division name

Department of Internal Medicine

Zip code


Address

2-2 Oote-cho, Obama-shi, Fukui, Japan

TEL

0770-52-0990

Homepage URL


Email

tnktya@gmail.com


Sponsor or person

Institute

Sugitagenpakukinen Kouritu Obama Hospital

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 07 Month 03 Day

Date of IRB

2017 Year 04 Month 01 Day

Anticipated trial start date

2017 Year 07 Month 24 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 03 Month 31 Day

Date trial data considered complete

2020 Year 09 Month 30 Day

Date analysis concluded

2020 Year 09 Month 30 Day


Other

Other related information

1. Study Design
Retrospective Cohort Study
2. Key inclusion criteria
1) Patients who underwent HD in Sugitagenpakukinen Kouritu Obama Hospital between April 1st 2011 and March 31st 2016.
2) Patients who underwent whole bone densitometry.
3) Age: Not applicable
4) Gender: Not applicable
5) Duration of HD/Primary disease of HD: Not applicable
3. Observation issue
1)Baseline Characteristics: patient's initials, gender, birth date, height, weight, complication, past history, medical record, medication history.
2) Patient's ADL
3)Biochemical test:Alb, Cre, TP, T-Cho, CRP
4) Whole bone densitometry: lean tissue mass (upper & lower limb)
5) BBS (Berg Balance Scale), TUG (Timed Up to Go), 10 meter walking test, FIM (Functional Independence Measure)


Management information

Registered date

2017 Year 07 Month 06 Day

Last modified on

2023 Year 07 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032113


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name